Ask the experts: biomarker-guided therapy in everyday oncology

About this Webinar

In routine practice, digital tooling shortens time-to-decision considerably, with meaningful differences between subgroups. Longitudinal data show that patient selection criteria deserve closer scrutiny, as discussed in the accompanying commentary. In multidisciplinary settings, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, with meaningful differences between subgroups. Contrary to earlier assumptions, integrating quantitative measures reduces subjective bias, as discussed in the accompanying commentary. Longitudinal data show that cross-disciplinary review changes the initial assessment in a sizeable minority of cases, and this trend is expected to continue.